The results that were obtained in this study indicated a significantly lower circulating vaspin concentration in obese patients with newly diagnosed T2DM before the implementation of metformin therapy, as compared to obese controls. This evidence concerns the gene SERPINA12 and type 2 diabetes mellitus.